Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 Replication by Hypertonic Saline Solution in Lung and Kidney Epithelial Cells

Full text
Author(s):
Show less -
Machado, Rafael R. G. [1] ; Glaser, Talita [2] ; Araujo, Danielle B. [1, 3] ; Petiz, Lyvia Lintzmaier [2] ; Oliveira, Danielle B. L. [1, 3, 4] ; Durigon, Giuliana S. [5] ; Leal, Alessandra L. [6] ; Pinho, Joao Renato R. [3, 7, 8] ; Ferreira, Luis C. S. [1, 9] ; Ulrich, Henning [2] ; Durigon, Edison L. [1, 9] ; Guzzo, Cristiane Rodrigues [1]
Total Authors: 12
Affiliation:
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, BR-05508 Sao Paulo - Brazil
[2] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508 Sao Paulo - Brazil
[3] Hosp Israelita Albert Einstein, BR-05652 Sao Paulo - Brazil
[4] Butantan Inst, Dev & Innovat Ctr, Lab Virol, BR-05503 Sao Paulo - Brazil
[5] Univ Sao Paulo, Med Sch Clin Hosp, BR-05508 Sao Paulo - Brazil
[6] Gaspar Vianna Clin Hosp Fdn, BR-66083 Belem, Para - Brazil
[7] Univ Sao Paulo, Clin Hosp, Sao Paulo Sch Med, Cent Labs Div, BR-05508 Sao Paulo - Brazil
[8] Univ Sao Paulo, Inst Trop Med, Dept Gastroenterol, LIM 07, Sch Med, BR-05508 Sao Paulo - Brazil
[9] Sci Platform Pasteur USP, BR-05508 Sao Paulo - Brazil
Total Affiliations: 9
Document type: Journal article
Source: ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE; v. 4, n. 5, p. 1514-1527, OCT 8 2021.
Web of Science Citations: 0
Abstract

An unprecedented global health crisis has been caused by a new virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We performed experiments to test if a hypertonic saline solution was capable of inhibiting virus replication. Our data show that 1.2% NaCl inhibited virus replication by 90%, achieving 100% of inhibition at 1.5% in the nonhuman primate kidney cell line Vero, and 1.1% of NaCl was sufficient to inhibit the virus replication by 88% in human epithelial lung cell line Calu-3. Furthermore, our results indicate that the inhibition is due to an intracellular mechanism and not to the dissociation of the spike SARS-CoV-2 protein and its human receptor. NaCl depolarizes the plasma membrane causing a low energy state (high ADP/ATP concentration ratio) without impairing mitochondrial function, supposedly associated with the inhibition of the SARS-CoV-2 life cycle. Membrane depolarization and intracellular energy deprivation are possible mechanisms by which the hypertonic saline solution efficiently prevents virus replication in vitro assays. (AU)

FAPESP's process: 20/06409-1 - Evaluation of humoral immune response and inflammatory response in patients with confirmed diagnosis of COVID-19 at Hospital Sírio Libanês and correlation with disease severity
Grantee:Edison Luiz Durigon
Support Opportunities: Regular Research Grants
FAPESP's process: 19/00195-2 - Understanding the c-di-GMP signaling networks and the Type II secretion system present into the human pathogen Leptospira interrogans Copenhageni
Grantee:Cristiane Rodrigues Guzzo Carvalho
Support Opportunities: Regular Research Grants
FAPESP's process: 18/07366-4 - Purine and kinin receptors as targets of study and therapeutic interventions in neurological diseases
Grantee:Alexander Henning Ulrich
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 17/24769-2 - Zika virus in postpartum women and newborns: seroepidemiology and molecular characterization
Grantee:Rafael Rahal Guaragna Machado
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 16/20045-7 - Antigen discovery and development of serological diagnostic methods and vaccine approaches against the Zika Virus (ZIKV)
Grantee:Luis Carlos de Souza Ferreira
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 20/04680-0 - Design of different fragments of SARS-CoV-2 surface protein spike for the development of fast diagnostic test and vaccine
Grantee:Cristiane Rodrigues Guzzo Carvalho
Support Opportunities: Regular Research Grants